Generic Name and Formulations:
Difluprednate 0.05%; oph emulsion.
Difluprednate是由Sirion Theraeutics公司研制开发的糖皮质激素受体激动剂，是泼尼松龙的氟化衍生物，具有抗炎活性，主要用于治疗手术后眼部感染和疼痛。Difupredate已于2008年6月由美国食品药品管理局（FDA）批准上市，商品名为Durezol。 

Company:
Alcon Laboratories, Inc.

Indications for DUREZOL:
Post-op inflammation and pain associated with ocular surgery.

Adult Dose for DUREZOL:
1 drop into affected eye(s) 4 times daily beginning 24hrs after surgery, continue for 2 weeks post-op, followed by 2 times daily for a week, then taper until resolved.

Children's Dose for DUREZOL:
Not recommended.

Pharmacological Class:
Steroid.

Contraindications:
Ocular fungal, viral, or mycobacterial infections.

Warnings/Precautions:
Do not administer while wearing contacts. Corneal or scleral thinning. Glaucoma. History of herpes simplex. Monitor IOP and for secondary infections in prolonged therapy (>10 days). Pregnancy (Cat.C). Nursing mothers.

Adverse Reactions:
Corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells and flare, conjunctival edema, blepharitis. May mask or exacerbate ocular infections. Prolonged use may increase: IOP, optic nerve damage, visual acuity and field defects, cataract formation, corneal perforation. May delay healing and increase bleb formation after cataract surgery.

How Supplied:
Emulsion—5mL